What is Fournier’s Gangrene?
Fournier’s Gangrene or necrotizing fasciitis is a life-threatening bacterial infection of the perineum: the area between the anus and the scrotum in males or anus and vulva in females. Usually via a small cut in the skin, the bacteria invade the muscles, blood vessels, and tissues of the perineum, spreading quickly to necrotize or destroy the tissue.
Cases of Fournier’s Gangrene have resulted in disfigurement, removal of genitals, surgical complications, and even death. This type of necrotizing fasciitis, or flesh-eating bacteria, can continue to spread past the perineum, scrotum, and penis to the thighs and abdomen.
Fournier’s Gangrene has affected 1.6 in 100,000 men in the US annually and mostly affects men between the ages of 50-79. The FDA says that diabetes plays a role in increasing the risk factor of developing Fournier’s Gangrene.
How is Fournier’s Gangrene Linked to Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors?
Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors such as Invokana, Jardiance, Farxiga, and Streglatro are used in patients with type 2 diabetes to help lower blood sugar by enabling the kidneys to remove sugar via urine. Jardiance (empagliflozin) is also prescribed to lower risk of heart attack and stroke in adults with heart disease or type 2 diabetes.
There are 29 million people living with diabetes; over 26 million of those cases are type 2 diabetes. It is estimated that almost two million patients have been prescribed SGLT2 inhibitors. While necrotizing fasciitis is rare, the FDA has reported 12 cases of Fournier’s Gangrene linked to the use of these medications, although it is estimated there may be many more unreported cases.
Why Choose Meyers & Flowers Trial Attorneys?
Meyers & Flowers is now taking on cases of Fournier’s Gangrene linked to SGLT2 inhibitors. Our attorneys have already taken on cases against Invokana (canagliflozin) which has caused a life-threatening condition and increased rate of amputations in some patients.
With vast experience in medical malpractice and a record of winning landmark cases against large medical firms both locally and nationally, Meyers & Flowers is among the best choice in SGLT2 inhibitor lawyers Chigaco has to offer.
The FDA issued a Safety Alert on August 29, 2018, about rare but serious infections of the genitals linked to SGLT2 inhibitors. This risk is required to be added to doctor’s prescribing information and to the patient medication guide. Patients are warned to seek immediate medical attention if the symptoms of Fournier’s Gangrene appear and advise patients that the symptoms can worsen quickly. As reported by the National Organization for Rare Disorders, the symptoms of this dangerous condition include:
- Pain, redness, or swelling in the genitals or anal area
- General feeling of unwellness
- Unpleasant odor from affected tissues
Contact Meyers & Flowers for Help
If you or a loved one have been prescribed Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors such as Invokana, Jardiance, Farxiga, and Streglatro and have developed a genital infection such as necrotizing fasciitis or Fournier’s Gangrene, please contact our team at Meyers & Flowers for a free consultation. Our record of multi-million dollar rewards from cases won against drug companies speaks for itself. Let us help you pursue compensation for medical bills, pain and suffering, and the emotional anguish associated with developing Fournier’s Gangrene after being prescribed a SGLT2 inhibitor medication.